Correlation Between Bausch Health and Helix BioPharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bausch Health and Helix BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bausch Health and Helix BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bausch Health Companies and Helix BioPharma Corp, you can compare the effects of market volatilities on Bausch Health and Helix BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bausch Health with a short position of Helix BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bausch Health and Helix BioPharma.

Diversification Opportunities for Bausch Health and Helix BioPharma

-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Bausch and Helix is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Bausch Health Companies and Helix BioPharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Helix BioPharma Corp and Bausch Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bausch Health Companies are associated (or correlated) with Helix BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Helix BioPharma Corp has no effect on the direction of Bausch Health i.e., Bausch Health and Helix BioPharma go up and down completely randomly.

Pair Corralation between Bausch Health and Helix BioPharma

Assuming the 90 days trading horizon Bausch Health Companies is expected to under-perform the Helix BioPharma. But the stock apears to be less risky and, when comparing its historical volatility, Bausch Health Companies is 5.4 times less risky than Helix BioPharma. The stock trades about -0.17 of its potential returns per unit of risk. The Helix BioPharma Corp is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  76.00  in Helix BioPharma Corp on September 3, 2024 and sell it today you would earn a total of  11.00  from holding Helix BioPharma Corp or generate 14.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Bausch Health Companies  vs.  Helix BioPharma Corp

 Performance 
       Timeline  
Bausch Health Companies 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Bausch Health Companies are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal fundamental indicators, Bausch Health displayed solid returns over the last few months and may actually be approaching a breakup point.
Helix BioPharma Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Helix BioPharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Bausch Health and Helix BioPharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bausch Health and Helix BioPharma

The main advantage of trading using opposite Bausch Health and Helix BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bausch Health position performs unexpectedly, Helix BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Helix BioPharma will offset losses from the drop in Helix BioPharma's long position.
The idea behind Bausch Health Companies and Helix BioPharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Commodity Directory
Find actively traded commodities issued by global exchanges